Literature DB >> 7691821

Identification of domains on the 39-kDa protein that inhibit the binding of ligands to the low density lipoprotein receptor-related protein.

I Warshawsky1, G Bu, A L Schwartz.   

Abstract

The low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor (LRP/alpha 2MR) binds and internalizes several plasma proteins including tissue-type plasminogen activator (t-PA) and alpha 2-macroglobulin-protease complexes (alpha 2M*). A 39-kDa protein that copurifies with LRP/alpha 2MR inhibits the binding and uptake of ligands by LRP/alpha 2MR, including t-PA and alpha 2M*. To define domains on the 39-kDa protein which are essential for inhibition of t-PA and alpha 2M* binding to LRP/alpha 2MR, we have generated bacterial expression constructs encoding discrete regions of the 39-kDa protein as fusion proteins with glutathione S-transferase. Inhibition of t-PA and alpha 2M* binding to LRP/alpha 2MR on rat hepatoma MH1C1 cells are shown to require amino acid residues 18-24 and 100-107 on the 39-kDa protein. Inhibition of t-PA but not alpha 2M* binding to LRP/alpha 2MR is also mediated by residues 200-225 and 311-319. The same 39-kDa protein constructs that inhibit alpha 2M* and t-PA binding to MH1C1 cells are able to bind directly to purified LRP/alpha 2MR immobilized on nitrocellulose. Thus, our studies demonstrate several specific regions on the 39-kDa protein which are required for the inhibition of t-PA and alpha 2M* binding to LRP/alpha 2MR.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691821

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation.

Authors:  M Zhuo; D M Holtzman; Y Li; H Osaka; J DeMaro; M Jacquin; G Bu
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

2.  The solution structure of the N-terminal domain of alpha2-macroglobulin receptor-associated protein.

Authors:  P R Nielsen; L Ellgaard; M Etzerodt; H C Thogersen; F M Poulsen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

3.  Receptor-associated protein interacts with amyloid-beta peptide and promotes its cellular uptake.

Authors:  Takahisa Kanekiyo; Guojun Bu
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

Review 4.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

5.  Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures.

Authors:  J Jordán; M F Galindo; R J Miller; C A Reardon; G S Getz; M J LaDu
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

6.  The receptor-associated protein (RAP) binds calmodulin and is phosphorylated by calmodulin-dependent kinase II.

Authors:  C M Petersen; L Ellgaard; A Nykjaer; F Vilhardt; H Vorum; H C Thøgersen; M S Nielsen; C Jacobsen; S K Moestrup; J Gliemann
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

7.  Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor.

Authors:  A E Mast; D A Higuchi; Z F Huang; I Warshawsky; A L Schwartz; G J Broze
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

8.  The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo.

Authors:  I Warshawsky; G Bu; A Mast; J E Saffitz; G J Broze; A L Schwartz
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Proteasome regulates the delivery of LDL receptor-related protein into the degradation pathway.

Authors:  Lora Melman; Hans J Geuze; Yonghe Li; Lynn M McCormick; Peter Van Kerkhof; Ger J Strous; Alan L Schwartz; Guojun Bu
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

10.  Functional domains of the receptor-associated protein (RAP).

Authors:  R A Orlando; M G Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.